
Joel Palefsky
Professor of Medicine and Laboratory Medicine · University of California (San Francisco) School of Medicine
Credentials: · · · ·
History
- 1983–1985
Infectious Disease
- 1980–1983
Internal Medicine
- 1976–1980
Research
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Science · 2018 · 3,112 citations
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males
New England Journal of Medicine · 2011 · 808 citations
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia
New England Journal of Medicine · 2011 · First of 16 authors · Corresponding · 686 citations

68 papers
- SG
46 papers

45 papers

44 papers

43 papers

42 papers
- SM
36 papers

35 papers
Grants
- 2019–2027
National Cancer Institute · U54
Contact PI · $10.2M · University of California, San Francisco
- 2022–2025
National Institute of Dental and Craniofacial Research · R56
PI · $747.1K · Comprehensive Cancer Center/ Univ/Pr
- 2016–2022
(PQ4) Anal HPV Infection and Anal HSIL Among HIV-Infected MSM Aged 50+ Years
National Cancer Institute · R01
Contact PI · $3.4M · University of California, San Francisco
- 2017–2020
New Therapeutic HPV Vaccines for HIV Infected Men and Women
National Cancer Institute · R01
Contact PI · $594.4K · University of California, San Francisco
Clinical trials
- 2027–2031
Principal investigator · Withdrawn
AIDS Malignancy Consortium
- 2027–2031
Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men
Principal investigator · Withdrawn
AIDS Malignancy Consortium
- 2026–2028
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
Principal investigator · Recruiting · Phase 2
University of California, San Francisco
- 2024–2027
Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)
Principal investigator · Active not recruiting
University of California, San Francisco



